Get informed when a big investor buys or sells
+ FollowOvervalued by 105.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $38.58 Million |
|---|---|
| Enterprise Value | $40.85 Million |
| Earnings per Share | $-0.01 |
| Beta | 0.39 |
| Outstanding Shares | 321,219,999 |
| P/E Ratio | -12.14 |
|---|---|
| PEG | 65.78 |
| Price to Sales | - |
| Price to Book Ratio | -0.12 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -12.8 |
| Enterprise Value to Net Income | -14 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -0.57 |
No data
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.09%▼ 0.00% |
|---|---|
| Total Invested | $36,560▼ 14.89% |
| Investors Holding | 20% |
Blue Biofuels, Inc., through its various subsidiaries, is committed to developing sustainable solutions in the renewable energy, biofuels, and bioplastics sectors. A core innovation for the company is its proprietary Cellulose-to-Sugar (...
Stockcircle shows 7 open-market insider sales for Blue Biofuels in the last six months from SEC Form 4 reports by executives, directors, and other insiders.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.